Cargando…
Plumbagin Ameliorates CCl(4)-Induced Hepatic Fibrosis in Rats via the Epidermal Growth Factor Receptor Signaling Pathway
Epidermal growth factor (EGF) and its signaling molecules, EGFreceptor (EGFR) and signal transducer and activator of transcription factor 3 (STAT3), have been considered to play a role in liver fibrosis and cirrhosis. Plumbagin (PL) is an extracted component from the plant and has been used to treat...
Autores principales: | Chen, Si, Chen, Yi, Chen, Bi, Cai, Yi-jing, Zou, Zhuo-lin, Wang, Jin-guo, Lin, Zhuo, Wang, Xiao-dong, Fu, Li-yun, Hu, Yao-ren, Chen, Yong-ping, Chen, Da-zhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624924/ https://www.ncbi.nlm.nih.gov/pubmed/26550019 http://dx.doi.org/10.1155/2015/645727 |
Ejemplares similares
-
Identification of linderalactone as a natural inhibitor of SHP2 to ameliorate CCl(4)-induced liver fibrosis
por: Zhang, Yi, et al.
Publicado: (2023) -
Plumbagin Ameliorates Diabetic Nephropathy via Interruption of Pathways that Include NOX4 Signalling
por: Yong, Rachel, et al.
Publicado: (2013) -
Plumbagin protects liver against fulminant hepatic failure and chronic liver fibrosis via inhibiting inflammation and collagen production
por: Wang, Huafeng, et al.
Publicado: (2016) -
Plumbagin attenuates Bleomycin-induced lung fibrosis in mice
por: Mehdizadeh, Saber, et al.
Publicado: (2022) -
Ursolic acid ameliorates CCl4‐induced liver fibrosis through the NOXs/ROS pathway
por: Gan, Dakai, et al.
Publicado: (2018)